PMID-25904023 – HCG-Based Combination Therapy Spermatogenesis Recovery
Wenker EP, Dupree JM, Langille GM, Kovac J, Ramasamy R, Lamb D, Mills JN, Lipshultz LI. The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. J Sex Med. 2015;12(6):1334-1337.
Quick Reference
| Property | Value |
|---|---|
| PMID | 25904023 |
| DOI | 10.1111/jsm.12890 |
| Year | 2015 |
| Journal | Journal of Sexual Medicine |
| Study Type | Case Series |
| Evidence Level | IV |
| Sample | 66 men with testosterone-related azoospermia or severe oligospermia |
| Peptide(s) Studied | HCG |
Key Findings
- 66 men presented with likely testosterone-related azoospermia or severe oligospermia
- HCG-based combination therapy (HCG + clomiphene or HCG + FSH) was used for recovery
- Spermatogenesis recovered in the majority of men within 6-12 months
- Mean time to recovery of sperm in the ejaculate was approximately 4-6 months
- HCG alone was sometimes insufficient; combination with clomiphene or FSH improved outcomes
- Approximately 3 million US men take testosterone, many unaware of fertility impact
Study Design
Retrospective case series of 66 men treated for testosterone-induced azoospermia or severe oligospermia. Treatment protocols included HCG 3000 IU 3x/week, often combined with clomiphene citrate 25-50 mg daily or recombinant FSH.
Limitations
- Retrospective case series design (no controls)
- Variable treatment protocols across patients
- Duration and dose of prior testosterone use varied considerably
- Self-selection bias (men seeking fertility)
- Single-center experience
Clinical Relevance
Demonstrates that testosterone-induced azoospermia is reversible in most men with HCG-based therapy. This is critically relevant for the estimated 3 million US men on TRT who may not have been counseled about fertility effects. The study supports HCG as the first-line agent for fertility recovery after testosterone use, often combined with other gonadotropins or SERMs.
Related
#research #case-series #HCG #evidence-level-IV